SEC Form D · Amendment · filed June 22, 2021
Orion Biotechnology Canada Ltd
Location
OTTAWA, ONTARIO, Z4
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Jason S. Burke · Ottawa, Ontario, CanadaExecJohn S. Jussup · Ottawa, Ontario, CanadaExecRudolf Bom · Ottawa, Ontario, CanadaDirectorTheresa S. Firestone · Ottawa, Ontario, CanadaDirectorThomas S. Hecht · Ottawa, Ontario, CanadaDirectorMark Groper · Ottawa, Ontario, CanadaExec · DirectorAnatole S. Klepatsky · Ottawa, Ontario, CanadaExec · DirectorDmytro S. Martynenko · Ottawa, Ontario, CanadaDirectorMichael Lavalle · Santa Monica, CADirectorGary D. Reaves Ii · Houston, TXExec · DirectorAlex T. Krueger · Stamford, CTExecJeffrey K. Quake · Stamford, CTDirectorECP Investment Advisors LLC · Dallas, TXExec · DirectorEmily Harburg · Chicago, ILDirectorJohn W. Honeybourne · Houston, TXExecJohn A. Hill · Stamford, CTDirectorRichard Kane · Boston, MADirectorDonald W. Wilson · Memphis, TNExec · DirectorKem W. Wilson Ill · Memphis, TNDirectorMclean W. Wilson · Memphis, TNExec · DirectorNicholas Campesi · Baton Rouge, LADirectorAngel Onuoha-Onyekuru · Conroe, TXExecGPE X GP Limited Partnership · Boston, MADirectorTomasso Montagni · New York, NYExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗